Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women
NCT01082718Phase 3Withdrawn
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of artesunate, mefloquine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Planned start Mar 2010; status: withdrawn.
02
Drugs
artesunatemefloquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01082718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082718.